Panacea Life Sciences Holdings, Inc. PLSH
0.08 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.066 Day range 0.066
0.0211 52-week range 0.14
- YTD
- +65.60%
- 1 year
- +18.29%
- Market cap
- 4.92M
- EPS (ttm)
- -0.67
- YTD return
- +65.60%
- 1-year return
- +18.29%
- Volume
- 100
- Avg volume
- 3.68K
- Open
- 0.066
- Previous close
- 0.0828
- Day's range
- 0.066 – 0.066
- 52-week range
- 0.0211 – 0.14
1Y +0.0068 (+8.95%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.00 | -0.06 | — | — |
| Aug 30, 2024 | Jun 1, 2024 | 0.00 | -0.07 | — | — |
| May 6, 2024 | Mar 1, 2024 | 0.00 | -0.09 | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | -0.13 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -0.13 | — | — |
| Aug 15, 2023 | Jun 1, 2023 | 0.00 | -0.11 | — | — |
News
Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits 
Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products 
Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area 
Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise 
Panacea Life Sciences Holdings, Inc. Celebrates National CBD Day (August 8th) By Shifting To An “Everyday Low Pricing Model” To Meet Customer Needs 
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers 
Marijuana Stock Movers For August 2, 2023 
Panacea Life Sciences Holdings, Inc. Continues Pursuit of High Growth Health and Wellness Products with Acquisition of Sierra Sage, LLC and Halucenex from Melodial Global Health (formerly Creso Pharma Limited) 
Panacea Life Sciences Holdings, Inc. Announces CBD/CBG Clinical Trial Findings for the Management of Irritable Bowel Symptoms 
Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast
Your note
Sign in to keep a note on PLSH — it syncs with the Stock Master app.